N
atural killer (NK) cells are a group of lymphocytes that contribute to early innate immune responses against a wide array of pathogens and some cancers (1) (2) (3) . NK cells exert their effects via the production of antiviral and immunoregulatory cytokines and also through cytotoxic activity and direct lysis of target cells (4) (5) (6) . Moreover, they can play a key role in immunoregulation, and they have been reported to either promote or limit adaptive immune responses to viral infections (7) (8) (9) (10) (11) (12) . NK cells are a heterogeneous population and progress through several developmental stages. These maturation states can be identified by cell surface expression of CD11b and CD27 and are associated with variations in NK cell functional capabilities (13, 14) . Throughout their lifetime, activation of NK cells can be regulated by a broad array of cytokines, microbial ligands, or molecules on the surfaces of target cells that interact with both activating and inhibitory receptors on the NK cell surface (15) (16) (17) . Several cytokines, particularly interleukin 12 (IL-12) and IL-18, are known to trigger gamma interferon (IFN-␥) production by NK cells in a potently synergistic manner (18) (19) (20) . However, the interactions between many other cytokines are less well defined. Given the wide array of distinct inflammatory environments that may arise during infection or coinfection with different pathogens, more thorough knowledge of cytokine interactions will be key to understanding regulation of NK cell functions.
Two of the most well-characterized mouse models of antiviral immunity are lymphocytic choriomeningitis virus (LCMV) and murine cytomegalovirus (MCMV) infection. These viruses induce distinct cytokine profiles and also share several key differences in their NK cell-mediated immune responses with LCMV being a relatively resistant to NK cells and MCMV being sensitive to NK cells (7) . Although NK cells become activated and exhibit cytotoxicity during LCMV infection, they may not be essential for protection (16, 21, 22) but could be involved in modifying subsequent antiviral T cell responses and act as a "rheostat-like" regulator of host immunity (7) . In contrast, NK cells play a critical role in the control of MCMV infection. In C57BL/6 mice, which are resistant to MCMV infection, up to 50% of NK cells express the activating Ly49H receptor (23) (24) (25) . This allows the NK cells to specifically recognize viral protein m157, expressed on the surfaces of MCMV-infected cells, which is essential for efficient control of the infection (7, (26) (27) (28) (29) . Therefore, MCMV infection offers the opportunity to examine NK cells that are not only activated by cytokines but also can respond directly to a defined viral ligand.
Here, we have examined the effects of 43 murine cytokines tested individually or in pairs to determine their relative ability to activate NK cells directly ex vivo. Moreover, we examined the effects of the top 10 most stimulatory cytokine pairs identified in this screen on NK cells during infection with two natural mouse pathogens, LCMV and MCMV. We found that cytokine-induced production of IFN-␥ by NK cells was reduced during early LCMV infection but returned to levels comparable to those observed in uninfected mice by 60 days postinfection. This inhibition was specific to IFN-␥ expression, as upregulation of membrane-bound CD69 and CD25 molecules following cytokine exposure was not dramatically affected. During MCMV infection, NK cell IFN-␥ responses to cytokine stimulation 7 days or Ͼ60 days postinfection were comparable to those of naive mice. MCMV-specific Ly49H-positive (Ly49H ϩ ) NK cells preferentially proliferated during early MCMV infection, as determined by bromodeoxyuridine (BrdU) incorporation. BrdU ϩ Ly49H ϩ NK cells were still detected Ͼ60 days postinfection, but they did not exhibit enhanced responsiveness to cytokine stimulation. These results help characterize key features of NK cell responsiveness to innate cytokines throughout the course of model virus infection and may be useful targets for future therapeutic interventions.
MATERIALS AND METHODS
Mice and viral infections. Female BALB/c and C57BL/6 mice were purchased from The Jackson Laboratory (Bar Harbor, ME). Mice were infected at 6 to 12 weeks of age via intraperitoneal injection of 2 ϫ 10 5 PFU LCMV-Armstrong or 5 ϫ 10 4 PFU MCMV (WT-BAC MW97.01, derived from the Smith strain). All animal experiments were reviewed and approved by the Oregon Health and Science University Institutional Animal Care and Use Committee.
Reagents. Recombinant murine cytokines (certified endotoxin free) were purchased from R&D Systems (Minneapolis, MN). Cytokines examined included IL-1␤, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-9, IL-10, IL-11,  IL-12, IL-13, IL-15, IL-17, IL-18, IL-19, IL-20, IL-21, IL-23, IL-27, IL-28,  IL-33, tumor necrosis factor alpha (TNF-␣), TNF-␤, CD27 ligand  (CD27L), CD40L, CD137L, TNF-related apoptosis-inducing ligand  (TRAIL) , TNF-related activation-induced cytokine (TRANCE), TNF-related weak inducer of apoptosis (TWEAK), B cell activating factor (BAFF), LIGHT (homologous to lymphotoxin, exhibits inducible expression and competes with herpes simplex virus glycoprotein D for binding to herpesvirus entry mediator, a receptor expressed on T lymphocytes), TNF-like cytokine 1A (TL1A), glucocorticoid-induced TNF receptor-related protein ligand (GITRL), transforming growth factor ␣ (TGF-␣), TGF-␤, vascular endothelial growth factor (VEGF), nerve growth factor (NGF), macrophage colony-stimulating factor (M-CSF), granulocytemacrophage colony-stimulating factor (GM-CSF), IFN-␣, IFN-␤, and IFN-␥. Anti-CD8␣ (53-6.7), anti-CD27 (LG.7F9), anti-BrdU (B44), and anti-IFN-␥ (XMG1.2) were purchased from BD Pharmingen. Anti-CD25 (PC61) was purchased from BioLegend (San Diego, CA), and anti-CD3 (17A2), anti-Ly49H (3D10), anti-CD69 (H1.2F3), anti-CD11b (M1/70), and anti-CD49b (DX5) were purchased from eBioscience (San Diego, CA). Aqua cell viability stain was purchased from Invitrogen (Carlsbad, CA). Bromodeoxyuridine (BrdU) was purchased from Sigma-Aldrich (St. Louis, MO) and administered once daily by intraperitoneal injection (1 mg) on days 3 to 6 postinfection.
Stimulations and staining. Spleens were pressed through 70-m nylon filters to create single-cell suspensions and depleted of red blood cells by NH 4 Cl lysis prior to direct ex vivo stimulation. For the initial screen of 1,849 cytokine pairs, all cytokines were used at a final concentration of 100 ng/ml to maximize potential IFN-␥ production. The top 10 most stimulatory cytokine combinations were then used at 10 ng/ml for subsequent experiments as indicated. Cells were stimulated with cytokines for 6 h in RPMI 1640 supplemented with 10% fetal bovine serum (FBS), 20 mM HEPES, penicillin-streptomycin, and L-glutamine at 37°C and 6% CO 2 . To assess cytokine production during stimulation, brefeldin A (2 g/ml) (Sigma-Aldrich, St. Louis, MO) was added during the final hour of incubation. Cells were stained overnight at 4°C with Aqua (to identify live cells) and antibodies to cell surface markers in phosphate-buffered saline (PBS) plus 1% fetal calf serum (FCS) with 0.1 mg/ml mouse IgG (SigmaAldrich) and 1 g/ml anti-CD16/32 (2.4G2; Fc block). For intracellular staining, cells were washed, fixed with 2% formaldehyde in PBS, permeabilized with Permwash (0.1% saponin [Sigma-Aldrich], 0.1% NaN 3 [Sigma-Aldrich], and 2% FBS in PBS) and stained for intracellular cytokines for 1 h. For detection of BrdU incorporation, formaldehyde-fixed cells were treated with Permwash plus 10% dimethyl sulfoxide (DMSO) for 10 min, fixed again with 2% formaldehyde, and treated with DNase (300 g/ml in PBS; Sigma-Aldrich) for 1 h at 37°C prior to intracellular staining. Data were acquired on an LSR Fortessa flow cytometer (BD, San Jose, CA) and analyzed using FlowJo software (Treestar, Ashland, OR).
Statistical analysis. A two-tailed Student's t test was used to evaluate the statistical significance of differences between groups. A P value of Ͻ0.05 was considered significant.
RESULTS
Cytokine-mediated activation of NK cells before and after acute LCMV infection. NK cell function can be regulated by a variety of cytokines. IL-12 is the prototypical innate cytokine capable of activating NK cells, and it acts synergistically with several other cytokines to elicit the production of IFN-␥. Mouse splenocytes were stimulated directly ex vivo with an array of individual and paired cytokines for 6 h, and production of the antiviral cytokine IFN-␥ was measured to assess NK cell activation (Fig. 1) . IL-12 alone induced IFN-␥ expression in ϳ17% of DX5-positive (DX5 ϩ ) CD3 Ϫ NK cells (Fig. 1A) . When IL-12 was paired with IL-10, IFN-␥ production was reduced by more than half (Fig. 1A) , similar to our observations in CD8 ϩ T cells (30) . In contrast, when IL-12 was paired with IL-15, IL-18, IL-33, TNF-␣, IFN-␣, or IFN-␤, there was synergistic enhancement of IFN-␥ production, with up to 70% of NK cells becoming IFN-␥ ϩ after exposure to the most potent cytokine pair identified, IL-12 plus IL-18 ( Fig. 1A and Table 1 ). The mean fluorescence intensity (MFI) of IFN-␥ staining correlates with the amount of IFN-␥ that is secreted in vitro (30), and we found that cytokine combinations that triggered the highest frequency of IFN-␥ ϩ cells also typically elicited the most IFN-␥ production as well ( Fig. 1A and data not shown). To verify that our observations were not mouse strain specific, we tested a representative panel of cytokine pairs in naive BALB/c and C57BL/6 mice (Fig. 1B) . In general, we found that NK cells from either mouse strain responded similarly to the cytokine combinations tested and showed the same hierarchy of cytokine-based activation. However, there was slightly higher cytokine responsiveness in NK cells from C57BL/6 mice compared to BALB/c mice for 8 of the 10 cytokine combinations examined. Since NK cells from C57BL/6 mice express both DX5 and NK1.1, we compared the relative responsiveness of the CD3 Ϫ DX5 ϩ and CD3 Ϫ NK1.1 ϩ populations to cytokine stimulation (Fig. 1C) . Following cytokine exposure, the CD3 Ϫ DX5 ϩ population demonstrated a modestly lower frequency of cells producing IFN-␥ compared to the CD3 Ϫ NK1.1 ϩ population. On average, the DX5 ϩ NK cell response to each cytokine combination reached 79% Ϯ 2% of that observed among the NK1.1 ϩ population. However, the overall hierarchy of cytokine-induced IFN-␥ production by these two NK cell popu-lations remained essentially the same regardless of which NK cell marker was used.
To further define the interactions among cytokines that regulate NK cell activation, we conducted a comprehensive analysis in which 43 commercially available cytokines were tested individually at a high concentration (100 ng/ml) and in all possible pairwise combinations (i.e., 1,849 cytokine pairs) for their ability to induce IFN-␥ production by NK cells from LCMV-infected mice (8 days or Ͼ60 days postinfection; data not shown). The top 10 most stimulatory cytokine pairs identified in this initial screen comprised 10 individual cytokines, and pairwise combinations of these cytokines were tested at 10 ng/ml in naive or LCMV-infected mice (Table 1 and IL-18 in naive and day 8 LCMV-infected mice, respectively). Previous studies (21) have also found that acute LCMV infection reduces IL-12 responsiveness of splenic NK cells in vivo, further supporting these direct ex vivo results. However, by 60 days postinfection, cytokine responsiveness had returned to a level comparable to that observed in naive animals ( Table 1 and Fig. 2 ). Differential regulation of CD69 or CD25 and IFN-␥ expression by NK cells. In addition to producing IFN-␥, activated NK cells upregulate several immunomodulatory molecules such as CD69 and CD25 on their cell surface in response to cytokine stimulation. These molecules are important because CD69 expression influences lymphocyte migration (31, 32) and CD25 regulates cellular proliferation (33) (34) (35) . Notably, while CD69 was upregulated on a high percentage of NK cells following cytokine stimulation, only a subset of these cells produced IFN-␥ (Fig. 2B ). For example, while more than 90% of NK cells from naive mice exposed to IL-15 plus IFN-␤ become activated as measured by CD69 expression, only 20% of these cells produce IFN-␥. CD25 upregulation was more closely matched with IFN-␥ production for most cytokine pairs (Fig. 2C) . Moreover, while IFN-␥ production following cytokine stimulation was reduced 8 days after LCMV infection, upregulation of CD69 and CD25 was not inhibited, indicating differential regulation of these secreted and surface-bound proteins at this stage of the antiviral immune response.
Ly49H ؉ NK cells proliferate during MCMV infection but do not exhibit enhanced cytokine responsiveness. During MCMV infection of C57BL/6 mice, NK cells expressing Ly49H are activated in a receptor-specific manner by viral protein m157 (23, 24) . Although typically classified as part of the innate immune system, recent studies have indicated that NK cells may display some characteristics traditionally associated with adaptive immunity, such as receptor-specific proliferation and the generation of long-lived "memory" cells with enhanced responsiveness to secondary exposure (36) (37) (38) (39) (40) (41) (42) . To examine this further, BrdU was administered to naive mice and MCMV-infected mice (days 3 to 6 postinfection) to assess proliferation of Ly49H ϩ NK cells (i.e., responsive to the MCMV m157-activating ligand) and Ly49H Ϫ NK cells. Splenocytes were examined 7 or Ͼ60 days postinfection, and BrdU incorporation by Ly49H ϩ and Ly49H Ϫ NK cells was measured by flow cytometry (Fig. 3A and B (Fig. 3A) , indicating dynamic changes in NK cell proliferation and turnover. By 60 days postinfection, a population of the NK cells that proliferated during early MCMV infection was readily detected, with approximately 2% of Ly49H ϩ NK cells remaining BrdU ϩ at this later time point. To determine whether the Ly49H ϩ NK cells that proliferated during the early stages of MCMV infection exhibit enhanced responsiveness to inflammatory cytokine stimulation, they were stimulated directly ex vivo with each of the top 10 most stimulatory cytokine combinations (Table 1) , and IFN-␥ was measured by flow cytometry (Fig. 3C) . When BrdU ϩ Ly49H ϩ cells were compared to BrdU Ϫ Ly49H ϩ cells, no significant difference in IFN-␥ production was detected at any of the time points examined. These data demonstrate that while Ly49H ϩ NK cells preferentially proliferate during the early stages of MCMV infection, a The top 10 cytokine combinations (10 ng/ml) that triggered IFN-␥ production by NK cells from naive mice or LCMV-infected mice 8 days or Ͼ60 days postinfection were ranked according to the percentage of live CD3 Ϫ DX5 ϩ NK cells producing IFN-␥. Spontaneous production of IFN-␥ in medium-only controls was typically Ͻ1%, and this background they do not become more responsive to cytokine-mediated stimulation during the memory phase of the antiviral immune response.
IFN-␥ responses by Ly49H
؉ and Ly49H ؊ NK cells during MCMV and LCMV infection. We compared cytokine-induced IFN-␥ production by "virus-specific" Ly49H ϩ NK cells and Ly49H Ϫ NK cells that lack the receptor for this key MCMV viral ligand. NK cells from naive mice, MCMV-infected mice 7 or Ͼ60 days postinfection, or LCMV-infected mice day 7 postinfection were stimulated directly ex vivo with the indicated cytokine pairs, and IFN-␥ production was measured by flow cytometry (Fig. 4A) . Ly49H ϩ cells consistently displayed a higher percentage of IFN-␥ ϩ cells than Ly49H Ϫ NK cells in response to the 10 cytokine pairs that were tested in naive or virusinfected mice.
Direct ex vivo cytokine stimulation led to substantial upregulation of both CD69 (Fig. 4B) and CD25 (Fig. 4C) (Fig. 2) , 4 cytokine combinations involving IL-12 induced IFN-␥ and CD69 expression at equal frequencies (Fig. 4B) . Cytokine combinations that involved IL-18 or IFN-␣/␤, on the other hand, triggered higher frequencies of CD69 ϩ NK cells in comparison to IFN-␥ ϩ NK cells. Cytokinemediated CD25 upregulation was more variable, but there was a slight trend toward preferential upregulation of CD25 expression over IFN-␥ production among NK cells stimulated with cytokine combinations involving IL-18 (Fig. 4C) . Seven days after LCMV infection, NK cells from C57BL/6 mice were similar to those found in LCMV-infected BALB/c mice (Fig. 2) and showed a reduction in IFN-␥ responses compared to naive mice (data not shown). However, this preferential downregulation of IFN-␥ responses was not observed on day 7 after MCMV infection among any of the NK cell populations studied (Fig. 4B and C) . It is unclear whether this difference is related to LCMV being relatively resis- tant to NK cells, whereas MCMV is considered to be more sensitive to NK cells (7) .
NK cells can exist in several maturation states that are associated with variations in their effector function capabilities (13, 14, 43) . Therefore, we examined CD27 and CD11b expression on cytokine-responsive Ly49H ϩ and Ly49H Ϫ NK cells to further define the NK cell population involved with IFN-␥ production in response to innate cytokine exposure. Ly49H ϩ NK cells typically displayed a more mature surface phenotype than Ly49H
Ϫ NK cells, with 85% of Ly49H ϩ cells expressing CD11b (compared to 48% CD11b ϩ Ly49H Ϫ cells). At 7 days postinfection, an even higher percentage of Ly49H ϩ NK cells were CD11b ϩ (95%), and the majority (84%) were CD11b ϩ CD27 Ϫ , representing the surface phenotype associated with the most potent effector function (13) . In contrast, only 16% of Ly49H Ϫ NK cells were CD11b ϩ . By 60 days postinfection, the phenotypes of both the Ly49H ϩ and Ly49H
Ϫ populations had returned to a profile similar to that observed in naive animals. The lower responsiveness of the total Ly49H Ϫ cell population, particularly at 7 days postinfection ( Fig.  4A ) was largely due to the high percentage of CD11b Ϫ CD27 Ϫ NK cells within the Ly49H Ϫ population that were almost completely unresponsive to cytokine stimulation (Fig. 4D) . To verify that CD11b expression was the determining factor in predicting NK cell responsiveness to inflammatory cytokines, the NK cell population was first gated on CD11b ϩ cells and then divided into Ly49H ϩ and Ly49H Ϫ subpopulations (Fig. 4E) . When only mature, CD11b ϩ NK cells were compared, there was no longer any significant difference between Ly49H ϩ and Ly49H Ϫ NK cells in terms of IFN-␥ responses to the top 10 most stimulatory cytokine combinations. Variation in the distribution of CD11b ϩ and CD11b Ϫ populations also explains the differences observed between the CD3 Ϫ DX5 ϩ and CD3 Ϫ NK1.1 ϩ NK cells in naive C57BL/6 mice shown in Fig. 1C . Following stimulation with each of the top 10 cytokine combinations, the average frequency of IFN-␥ ϩ CD3 Ϫ DX5 ϩ cells was 79% Ϯ 2% of the frequency of the IFN-␥ ϩ cells observed among the CD3 Ϫ NK1.1 ϩ population (Fig.  1C) . However, this appears to be due to differences in CD11b expression among these NK cell populations. When only CD11b ϩ NK cells were examined, the IFN-␥ responses of the CD11b ϩ
CD3
Ϫ DX5 ϩ cells were essentially identical (99.8% Ϯ 0.7%) to the CD11b ϩ CD3 Ϫ NK1.1 ϩ responses. Collectively, our data indicate that the underlying maturation state of the cell (i.e., CD11b ϩ and/or CD27 ϩ ), rather than the expression of a specific receptor (i.e., Ly49H), is more closely associated with enhanced IFN-␥ responses to cytokine-mediated NK cell activation.
DISCUSSION
Cytokines play an essential role in regulating NK cell activation and are likely to be involved with effective innate antiviral immune responses. Since different pathogens induce unique cytokine profiles during the course of infection, innate immune cells may be exposed to a vast array of cytokine combinations that work in a combinatorial fashion to regulate cellular functions such as proliferation, cytotoxicity, and IFN-␥ production. We have previously performed a comprehensive screen of 1,849 cytokine pairs that regulate innate activation of virus-specific CD8 ϩ T cells in an antigen-independent manner (30) . Here, we provide an analysis of cytokine-mediated NK cell activation. In addition to identifying the most stimulatory cytokine combinations capable of inducing IFN-␥ production in NK cells, we demonstrated differences in NK cell functionality at different stages of LCMV and MCMV infection. Moreover, although we found that Ly49H ϩ "memory" NK cells that arose during MCMV infection did not show enhanced responsiveness to cytokine stimulation, we identified CD11b ϩ NK cells as the most responsive subset to cytokine-mediated activation regardless of Ly49H expression profile.
Several striking similarities emerged between cytokine combinations that regulate CD8 ϩ T cells and NK cells. For example, the combination of IL-12 plus IL-18 remains the most potent activating cytokine pair for both CD8 ϩ T cells and NK cells. For both cell types, IL-12 acted synergistically with a variety of cytokines to induce IFN-␥ production, including IL-33, an IL-1 family member that has only recently been recognized for its immune activating capabilities but was originally classified as a Th2-promoting cytokine (44, 45) . Moreover, 8 of the top 10 most stimulatory cytokine combinations were the same for NK cells and CD8 ϩ T cells, and all 10 of these combinations utilize either IL-12 or IL-18. In other words, although IL-12 and IL-18 represent only ϳ5% of the 43 cytokines examined, they are involved in 100% of the 10 most stimulatory cytokine combinations for NK cell-mediated IFN-␥ production (Table 1) . It is remarkable that from the Ͼ1,800 cytokine combinations tested, only IL-12 and IL-18 form the foundation for cytokine-mediated NK cell activation. Interestingly, the responsiveness of NK cells and CD8 ϩ T cells to cytokine stimulation evolve quite differently over the course of LCMV infection. Eight days after LCMV infection, NK cell-mediated IFN-␥ responses to inflammatory cytokines were reduced, and this is in contrast to LCMV-specific CD8 ϩ T cells that were highly responsive to cytokine stimulation at this time point (30) . Similar to observations of virus-specific CD8 ϩ T cells (30, 46, 47) , several cytokine combinations induced CD69 and/or CD25 upregulation in a majority of NK cells (e.g., IL-18 plus IFN-␤) but only triggered IFN-␥ production in a more limited subset of the NK cells. These differences were more pronounced in NK cells from BALB/c mice ( Fig. 2B and C) than those from C57BL/6 mice ( Fig. 4B and C) . This indicates that although NK cells are becoming activated by cytokine exposure, their production of the antiviral and immunoregulatory cytokine IFN-␥ is restrained in certain circumstances. Such differential regulation of secreted proteins versus cell surface proteins could potentially be an important mechanism for reducing immunopathology during infection while still maintaining or enhancing an effective immune response. Although NK cells have traditionally been classified as part of the innate immune system, recent studies suggest that they may also exhibit some characteristics associated with adaptive immunity. For example, a population of memory-like NK cells that arise during MCMV infection has been described (38, 41, 42, 48) . Much like CD8 ϩ T cells, Ly49H ϩ NK cells can undergo ligand-specific proliferation, followed by a contraction phase with some cells surviving to become long-lived cells that persist beyond 70 days postinfection. These cells are protective against subsequent MCMV challenge in an adoptive transfer model and show enhanced IFN-␥ production in response to anti-Ly49H or anti-NK1.1 stimulation (48), but their innate responses to cytokinemediated activation have not been fully characterized. We found that Ly49H ϩ NK cells preferentially proliferated during the early course of MCMV infection (Fig. 3) , and a long-lived population of BrdU ϩ Ly49H ϩ NK cells was still detected beyond 60 days postinfection. However, the BrdU ϩ Ly49H ϩ NK cells did not show a functional advantage over BrdU Ϫ Ly49H ϩ cells with respect to their production of IFN-␥ upon exposure to cytokine stimulation (Fig. 3C ). This is in contrast to the enhanced responsiveness of Ly49H ϩ memory NK cells to stimulation through the Ly49H receptor following MCMV infection (48) . This suggests that memory NK cells may exert some degree of specificity in their recall responses by mounting distinct responses to cell surface ligands versus secreted cytokines. A similar phenomenon has been observed in CD8 T cells. Effector and memory CD8
ϩ T cells regulate their responses to peptide antigen on the surface of an infected cell differently than when activated by soluble innate cytokines, both in terms of the cytokines they produce (e.g., TNF-␣ and IL-2 are produced upon exposure to peptide antigen, but not IL-12 plus IL-18) and their sensitivity to regulatory control by inhibitory cytokines (47, 49) . Given the array of different cell surface receptors that govern NK cell activation (e.g., cytokine receptors, Ly49H, and other activating and inhibitory receptors), it is possible that similar mechanisms exist for NK cells to fine-tune their responses to their local microenvironment.
Notably, expression of Ly49H alone was not predictive of cytokine responsiveness. It has previously been demonstrated that CD11b and CD27 expression can be used to segregate NK cells into functionally distinct subsets, with cells expressing high levels of CD11b being the most mature in terms of IFN-␥ production and cytolytic activity (13, 43) . Although Ly49H ϩ NK cells appeared to be more responsive to cytokine stimulation than Ly49H Ϫ NK cells, when these cell populations were first normalized to contain only CD11b ϩ cells, then there were no longer any differences in innate responses to cytokine exposure (Fig. 4E) . Therefore, the differences in IFN-␥ responses by Ly49H ϩ and Ly49H Ϫ cells appear to be related to differences in the distribution of functionally mature CD11b ϩ and/or CD27 ϩ NK cells within these two populations (Fig. 4D) . While expression of Ly49H alone may not predict cytokine responsiveness, it is possible that stimulation through the Ly49H receptor could be involved in the maturation process or in the rescue of activated NK cells during viral infection, resulting in a higher proportion of CD11b ϩ cells within the Ly49H ϩ population. In this way, Ly49H may be involved with influencing cytokine responsiveness in an indirect manner, but more studies are needed to determine whether this is indeed the case. Collectively, our data help to define cytokine interactions, phenotypes, and cellular characteristics that govern NK cell activation during the course of viral infection. This information may be useful for future development of NK cell-based therapeutics and/or manipulation of the NK cell "rheostat" that serves to balance antiviral immune responses (7, 8) .
